Semi-Annual Consolidated Balance Sheet

Nxera Pharma Co., Ltd. - Filing #7272710

Concept As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
Semi-annual consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
6,449,000,000 JPY
21,989,000,000 JPY
Inventories
8,362,000,000 JPY
JPY
Other
1,277,000,000 JPY
61,000,000 JPY
Current assets
16,999,000,000 JPY
39,899,000,000 JPY
Non-current assets
Property, plant and equipment
8,000,000 JPY
39,000,000 JPY
Property, plant and equipment
Intangible assets
Other
JPY
0 JPY
Intangible assets
43,002,000,000 JPY
43,368,000,000 JPY
Investments and other assets
76,118,000,000 JPY
58,705,000,000 JPY
Investments and other assets
Other
JPY
58,000,000 JPY
Allowance for doubtful accounts
JPY
-3,318,000,000 JPY
Non-current assets
119,128,000,000 JPY
102,112,000,000 JPY
Assets
136,127,000,000 JPY
142,011,000,000 JPY
Liabilities
Current liabilities
Income taxes payable
64,000,000 JPY
79,000,000 JPY
Other
70,000,000 JPY
13,000,000 JPY
Current liabilities
8,249,000,000 JPY
11,062,000,000 JPY
Non-current liabilities
Long-term borrowings
26,950,000,000 JPY
32,750,000,000 JPY
Asset retirement obligations
JPY
18,000,000 JPY
Non-current liabilities
59,823,000,000 JPY
65,749,000,000 JPY
Bonds with share acquisition rights
32,633,000,000 JPY
32,793,000,000 JPY
Liabilities
68,072,000,000 JPY
76,811,000,000 JPY
Provision for bonuses
250,000,000 JPY
JPY
Provision for bonuses for directors (and other officers)
314,000,000 JPY
JPY
Net assets
Shareholders' equity
Share capital
47,172,000,000 JPY
46,807,000,000 JPY
Capital surplus
35,289,000,000 JPY
34,924,000,000 JPY
Retained earnings
-14,621,000,000 JPY
-16,765,000,000 JPY
Treasury shares
-3,000,000 JPY
-1,000,000 JPY
Shareholders' equity
67,837,000,000 JPY
64,965,000,000 JPY
Valuation and translation adjustments
Valuation difference on available-for-sale securities
-15,000,000 JPY
0 JPY
Valuation and translation adjustments
-15,000,000 JPY
0 JPY
Share acquisition rights
233,000,000 JPY
235,000,000 JPY
Net assets
233,000,000 JPY
-14,621,000,000 JPY
35,289,000,000 JPY
68,055,000,000 JPY
47,172,000,000 JPY
-3,000,000 JPY
-15,000,000 JPY
67,837,000,000 JPY
0 JPY
235,000,000 JPY
46,807,000,000 JPY
65,200,000,000 JPY
-16,765,000,000 JPY
64,965,000,000 JPY
34,924,000,000 JPY
-1,000,000 JPY
-1,000,000 JPY
57,544,000,000 JPY
29,452,000,000 JPY
57,306,000,000 JPY
-5,000,000 JPY
41,335,000,000 JPY
-13,480,000,000 JPY
243,000,000 JPY
Liabilities and net assets
136,127,000,000 JPY
142,011,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.